Kistenuyck T.S., Skrotska O.I.
The
scientific information on biological activity of ceria dioxide nanoparticles
(CeO2) is still very fragmentary. It is known, that nanoceria
interaction with biological systems is based on two principal properties of
this substance: low toxicity and high reducibility [1]. These factors
determines activity of nanoceria in biological redox processes, especially in
inactivation of reactive oxygen species, including free radicals that are
formed inside living cells.
Moreover,
vacancy engineered ceria nanostructures can protect from radiation-induced
cellular damage and can prevent retinal degeneration caused by ultraviolet (UV)
irradiation. It should also be noted
that UV-extinction coefficient of ceria is rather high; therefore this compound
is considered a promising UV-filter in sunscreen cosmetics
[2]. According to a recent
study performed by GEMATRIA Test Lab (Germany), could be judged a key component
of future sunscreen cosmetics because it protects from both sunlight and free
radicals [3].
The
industrial applications includes its uses as a polishing agents, ultraviolet
absorbing compound in sunscreen, solid electrolytes in solid oxide fuel cells,
as a fuel additive to promote combustion [4]. However, it is in the biomedical
industry CeO2 is gaining much attention because of their antioxidant
properties [5].
Antiviral
activity of nanoceria to date been
studied very little. Ukrainian scientists first showed inhubuyuchyy impact sols
nanoceria, which were
stabilized low molecular weight poliakrylovoy acid (PAA), the development of
cytopathic effect (CPS) test vesicular stomatitis virus (BBC family Rhabdoviridae)
provided 24-hour pre-contact culture reference fibroblast cell line mice (L929) and epithelial cells of embryos of
pigs testicles (PST) [6].
It
was found that prophylactic treatment of both cell cultures at a concentration
of nanoceria zolyamy 2,0-10,0
mg/ml caused the formation of antiviral resistance of cells [7]. In these
studies first showed that nanoceria stabilized by citrate also gave an inhibitory effect on the development
of the CPS test virus BBC. In terms
of in vitro formation of 100%
antiviral resistance observed in both prophylactic and therapeutic regimens.
Also found that CeO2 significantly inhibits the reproduction of
viruses in model systems L929/BBC and RF/HSV-1: the virus titer reduction was
2,6-4,8 lg. These data are of great practical interest, however, in these
studies revealed no possible mechanism nanoceria antiviral activity [8].
Simplified
diagram of retrovirus replication in a system with agents based on cerium
dioxide Nanodispersed. Extracellular virions enter the host cell, mainly by
means of viral fusion proteins that interact with receptors on the plasma
membrane. After adsorption of the virus on the cell surface, the virus
penetrates the cell in two ways. In the first case, the virus penetrates the
cell membrane by fusion with the plasma membrane, and hereditary material
appears to cells (typical of herpes viruses).
In
the second case, the result of endocytosis of cell penetrating vesicles
containing virions. In this state, the virus is packaged in an extra shell
formed by the cell membrane. From the second shell it is discharged at the
confluence of vesicles from endosomes, where the acidic environment activates
fusion proteins and thus contributes to the unification of the virion membrane
with endosomalnoyu membrane and then released into the cytoplasm of hereditary
material.
This
way the most common and characteristic of many complex viruses, such as for
influenza virus. After the "strip" genomic RNA is transcribed into
double-stranded DNA copy that is imported into the nucleus. At the core of the
viral genome DNA is integrated into the chromosome of the host cell and serves
as a template for synthesis of viral mRNA. Then viral mRNAs are transported to
the cytoplasm, where the synthesis of viral GAG - polyprotein and the
glycoprotein shell. Then, the assembly of the virus particles, and then virus
particle reaches the plasma membrane or endosomalnoyi and uses it to form new
virions, which is able to participate in the next infectious cycle. The
penetration of the virus into the cell causes the formation of reactive oxygen
species (ROS). On the one hand, ROS play a positive role in the destruction of
viruses, since cell peroxisomes (along with mitochondria) is one of the most
important parts of the development stage of antiviral innate immune responses.
On the other hand, the AFC supports the inflammatory process, causing
destructive changes in cells and tissues, in some cases irreversible. They
initiate the process of lipid peroxidation of cell membranes, resulting in loss
of barrier function in tissues and organs there is structural and functional
disorders.
Typically,
existing antiviral drugs designed to inhibit certain stages of viral infection.
Thus, a number of drugs (eg oksolin) block extracellular virions. The following
drugs (Remantadun, Arbidol, Tamiflu) prevent adsorption, membrane penetration
and removal of viruses. Others are able to inhibit the synthesis of viral RNA/DNA (azo-Azina oligonucleotides
ribavirin) or synthesis of proteins (interferons and their inducers, protease
inhibitors). A number of drugs are inhibitors of folding or prevent the release
of virions offspring (interferons) [9].
Until
recently, nanomaterials regarded only as a means of delivery of biologically
active molecules in the center of viral infection [10]. In recent years, there
have been reports of independent antiviral activity of nanoparticles without
the prior modification of special structures. Yes, shows activity of titanium
dioxide nanoparticles (with a particle size of 4-5 nm) with respect to
influenza A virus (H3N2). According to electron microscopy after 15 min after
the addition of TiO2 nanoparticles in a liquid that contains viruses, data
structures adsorbed on the outer shell of viruses and cause local destruction,
which in turn leads to the loss of infectious virus activity [11].
It
is believed that the antiviral effect of nanoparticles can be directed to
different targets in the reproduction cycle of viruses. Consider multiple
mechanisms of antiviral action of cerium dioxide nanoparticles in the table.
Thus, due to the
adsorption of viral proteins NDC-1) or receptors cells NDC-2) nanoparticles can
block extracellular virions and hinder their adsorption on cell membranes.
Viruses that enter the cell via endocytosis (eg, influenza virus), for
agglutination and release of hereditary material reduces the pH content of the
vesicles.
The mechanism of antiviral action of CeO2
nanoparticles
|
Targets the drug NDC |
Mode of action of nanoparticles per cell and virus |
|
NDC -1 |
effect
on viral receptors (nezdaten virus attach to the cell surface) |
|
NDC -2 |
effect
on cell
receptors, what hinders virus adsorbed on the surface |
|
NDC -3 |
damage
to viral nucleic acids |
|
NDC -4 |
інгібування
транскрипції вірусної РНК |
|
NDC -5 |
hinders
"drawing up" virus |
|
NDC -6 |
hinders
release of virus from cells |
Thus, the
hemagglutinin of influenza virus at pH = 7 inactive. Fusion peptide alters
conformation only in acidic medium (pH ≤ 5). This pH nanocrystalline
cerium dioxide reveals are expressed oxidant properties and can damage nucleic
acids virion NDC-3).
Studies show that
the physico-chemical point of view CeO2 nanoparticles can non-specifically
adsorbed on the surface of both the virus and provide a mechanism for blocking
SIC - 1 dimensions virus can be considered as an object of near-field physics.
If the virus will be located near nanochastyky CeO 2 is between the virus
particle and interaction may be due to fluctuating fields (similar to Vander
Waals forces). It is hoped that this interaction will lead to irreversible
transformation of the system. For example, can collapse the weak chemical bonds
that are part of the education of receptors the viral capsid [12, 13].
This mechanism
allows two ways to reduce viral activity. On the one hand, the adsorption of
the particles prevents the penetration of the virus into living cells. Firstly,
thanks very stable formation of "virus - nanoparticle" can be
considered that this system has the geometric characteristics that differ from
the characteristics of the virus. Since the permeability of the virus through
the cell membrane is largely determined by the geometric factor of virus
attached nanoparticles mainly lose their ability to penetrate into cells.
Secondly, due to the local field on receptors located on the surface of the
virus, molecular groups of receptors can be modified up to their destruction.
Indeed, because the effective susceptibility tensor can be sufficiently large
values, the local field the viral particle is greatly enhanced.
Since the virus receptors interact with relevant education on the cell membrane
of the principle of complementarity (interaction type key-lock), then any
damage to the receptor leads to the impossibility of the virus into the cell.
Thirdly, the local field can have on the virus particle thermal effect. Due to
local heating of viral capsids latter may lose their properties and activity of
the virus will also be reduced [11].
In in vitro
experiments, it was shown that the NDC (0.1 M the aqueous solution of colloidal
CeO 2 particles with a size of 2-4 nm, stabilized sodium citrate) effectively
inhibits the reproduction of influenza virus in cell culture inoculated dog
kidney (MDSK) at a dose of 1.25 mM . As a comparison using drugs Tamiflu
(Hoffman La Rosh USA) Remantadun (Russia) [14].
After this study, it
was suggested that one of the main mechanisms of inhibition of reproduction of
herpes virus is blocking nonspecific hemagglutinin and neuraminidase of the
virus (NDC mechanism - 1), which affects the stages of adsorption and fusion of
the virus with the cell membrane and the exit of the virus from the cell with
the release of virus particles from the cell membrane after budding. Perhaps
activity blockade surface antigens hemagglutinin and neuraminidase of influenza
virus is due to incorporation of nanoparticles in glycoprotein structure
surface antigens of influenza virus and change their conformation or due to
overlapping of nanoparticles receptors hemagglutinin and neuraminidase active
site of interaction with the substrate or erythrocytes.
Use
of the drug reduced the severity of symptoms CeO2 to 29.0 points,
which corresponds to the therapeutic effect on the level of 63.8% (p <0.05),
and significantly reduced the duration of illness. At therapeutic scheme of CeO2
decreased symptoms to score 31 level, the therapeutic effect was 61.3%,
duration of disease in animals was 8 days, which is statistically significant
for all parameters differ from the control of herpes virus and indicates the
efficacy of this dose [12 ].
Mechanisms
of antiviral action сeria dioxide nanoparticles are of particular
interest for further analysis because open perspective of CeO2 in
the prevention and treatment of viral diseases.
References:
1.
Shcherbakov A.B, Ivanov V.K, Zholobak N.M. Nanocrystaline eeria based materials-perspectives for biomedical application // Biofizika. – 2011.
− Vol. 56 − P. 995-1015.
2.
Zholobak N.M,Ivanov V.K, Shcherbakov A.B. UV-shieldingproperty, photocatalyticactivityandphotocytotoxicityofceriacolloidsolutions // .J. Photochem.Photobiol. – 2011. − Vol. 102 − P.
32-38.
3.
Herrling T., Seifert M., Jung K., Cerium dioxide: future UV-filter in sunscreen? // SOFT – Jornal. – 2013. − Vol. 139 − P. 10-14.
4.
Vishal M., Shreya К., Hirsh А. Antibacterial activity of polymer coated cerium
oxide nanoparticles // Biofizika. – 2011.
− Vol. 50 − P. 675-682.
5.
Щербаков А.Б., Жолобак Н.М.,
Иванов В.К. Синтез
и антиоксидантная активность
биосовместимых водных
золей нанокристаллического диоксида церия декстраном // Журн.
неорган. химии. – 2012. – Т. 57, № 11. – С. 5–9.
6.
Иванов B.K., Полежаева О.С., Шапорев А.С. Синтез и исследование
термической устойчивости золей нанокристаллического диоксида церия,
стабилизированных лимонной и полиакриловой кислотами // Журн. неорган. химии.
–2010. – Т. 55, № 3. – С. 368−373.
7.
Жoлобак Н.М., Олевинская
З.М., Спивак Н.Я.
Антивирусное действие наночастка диоксида церия, стабилизированных
низкомолекулярной полиакриловой кислотой // Мікробіол. журн. – 2010. –Т. 72, №
3. – С. 42–47.
8.
Zholobak
N.M., Shcherbakov A.B., Ivanov V.K., Spivak N.Y. Antiviral effectivity of
ceria colloid solutions // Mater. Res. Bull. − 2011. − Vol. 46 − P. 2589–2591.
9.
Ершов Ф.И., Касьянова Н.В. Современные средства терапии наиболее
распространенных вирусных инфекций // Cons. med. − 2004. − Т.6, №1. − С.51–57.
10.
Lembo D.N., Cavalli R.D. Nanoparticulate delivery systems for antiviral drugs // Antivir. Chem. Chemother. − 2010.
− Vol.21, №2. − P.53–70.
11.
11. Загребельный С.Н., Мазуркова Н.А., Спицына Ю.Е. Взаимодействие
наночастиц диоксида титана с вирусом гриппа // Рос. нанотех. − 2010.
− Т.5, № 5–6. − С.125−127.
12.
Lozovski V., Lysenko V., Scherbakov A., Zholobak N.,
et al.
Physical point of view for antiviral effect caused by the interaction between
the viruses and nanoparticles // J. Bionanosci. − 2012. −Vol.6, №2. −
P.109-112.
13.
Girard C., Joachim C., Gauthier S. The physics of the
near-field //Rep. Prog. Phys. − 2000. − Vol.63. − P.893-938.
14.
Иванов В.К.,
Полежаева О.С., Щербаков А.Б. и др. Синтез и исследование термической устойчивости золей
нанокристаллического диоксида церия, стабилизированных лимонной и полиакриловой
кислотами // Журн. неорган. химии. − 2010. − Т.55, №3. −
С.368-373.